Nasal virus infection induces asthma exacerbation through B-cell-dependent recruitment of inflammatory monocytes.

Autor: Waldstein KA; Department of Otolaryngology-Head and Neck Surgery, University of Iowa, Iowa City, Iowa, USA., Issimov A; Department of Otolaryngology-Head and Neck Surgery, University of Iowa, Iowa City, Iowa, USA., Ganama M; Department of Otolaryngology-Head and Neck Surgery, University of Iowa, Iowa City, Iowa, USA., Jinge V; Department of Otolaryngology-Head and Neck Surgery, University of Iowa, Iowa City, Iowa, USA.; Department of Otorhinolaryngology-Head and Neck Surgery, University of Texas Health Science Center at Houston, Houston, Texas, USA., Tilley S; Department of Medicine, Division of Pulmonary Diseases and Critical Care Medicine and the Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Hua X; Department of Otolaryngology-Head and Neck Surgery, University of Iowa, Iowa City, Iowa, USA.; Department of Otorhinolaryngology-Head and Neck Surgery, University of Texas Health Science Center at Houston, Houston, Texas, USA.

Publikováno v: International forum of allergy & rhinology [Int Forum Allergy Rhinol] 2024 Dec; Vol. 14 (12), pp. 1857-1868. Date of Electronic Publication: 2024 Aug 07.

Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape.

Autor: Mazur NI; Department of Paediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, Netherlands., Terstappen J; Department of Paediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, Netherlands., Baral R; PATH, Center for Vaccine Innovation & Access, Seattle, WA, USA., Bardají A; ISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain; Centro de Investigaçao em Saúde de Manhiça, Maputo, Mozambique; Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública, Madrid, Spain., Beutels P; Centre for Health Economics Research & Modelling Infectious Diseases, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium; School of Public Health, The University of New South Wales, Sydney, NSW, Australia., Buchholz UJ; RNA Viruses Section, Laboratory of Infectious Diseases, National Institutes of Health, Bethesda, MA, USA., Cohen C; University of the Witwatersrand, Centre for Respiratory Disease and Meningitis at the National Institute for Communicable Diseases, Johannesburg, South Africa; School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Crowe JE Jr; Vanderbilt Vaccine Center, Pediatrics & Pathology, Microbiology & Immunology, Vanderbilt University Medical Center, Nashville, TN, USA., Cutland CL; African Leadership in Vaccinology Expertise, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Eckert L; Obstetrics & Gynecology, Global Health, University of Washington, Seattle, WA, USA., Feikin D; Department of Immunisations, Vaccines & Biologicals, World Health Organization, Geneva, Switzerland., Fitzpatrick T; Yale School of Public Health Department of Epidemiology of Microbial Diseases, Yale University, New Haven, CT, USA., Fong Y; Vaccine & Infectious Disease Division, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Department of Biostatistics, University of Washington, Seattle, WA, USA., Graham BS; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MA, USA., Heikkinen T; Department of Pediatrics, University of Turku and Turku University Hospital, Turku, Finland., Higgins D; PATH, Center for Vaccine Innovation & Access, Seattle, WA, USA., Hirve S; Global Influenza Programme, World Health Organization, Geneva, Switzerland., Klugman KP; Pneumonia Program, Bill & Melinda Gates Foundation, Seattle, WA, USA., Kragten-Tabatabaie L; ReSViNET Foundation, Julius Clinical, Zeist, Netherlands., Lemey P; Clinical and Epidemiological Virology, Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium., Libster R; Fundacion INFANT, Buenos Aires, Argentina., Löwensteyn Y; Department of Paediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, Netherlands., Mejias A; Nationwide Children's Hospital Columbus, Columbus, OH, USA., Munoz FM; Department of Pediatrics, Division of Infectious Disease, and Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA., Munywoki PK; Kenyan Medical Research Institute-Wellcome Trust Research Program, Kilifi, Kenya., Mwananyanda L; Department of Global Health, Boston University, Lusaka, Zambia., Nair H; Centre for Global Health, Usher Institute, University of Edinburgh, Edinburgh, UK., Nunes MC; South African Medical Research Council, Wits Vaccines & Infectious Diseases Analytics Research Unit and Department of Science and Technology and National Research Foundation, South African Research Chair Initiative in Vaccine Preventable Diseases, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Ramilo O; Nationwide Children's Hospital Columbus, Columbus, OH, USA., Richmond P; School of Medicine, Division of Paediatrics, University of Western Australia, Perth, WA, Australia., Ruckwardt TJ; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MA, USA., Sande C; Kenyan Medical Research Institute-Wellcome Trust Research Program, Kilifi, Kenya; Centre for Tropical Medicine & Global Health, University of Oxford, Oxford, UK., Srikantiah P; Respiratory Syncytial Virus Program and Global Health, Bill & Melinda Gates Foundation, Seattle, WA, USA., Thacker N; Deep Children Hospital & Research Centre, Gandhidham, India., Waldstein KA; Department of Microbiology and Immunology, University of Iowa, Iowa, IA, USA; Interdisciplinary Graduate Program in Immunology, University of Iowa, Iowa, IA, USA., Weinberger D; Yale School of Public Health Department of Epidemiology of Microbial Diseases, Yale University, New Haven, CT, USA., Wildenbeest J; Department of Paediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, Netherlands., Wiseman D; National Heart & Lung Institute, Imperial College, London, UK., Zar HJ; Department of Pediatrics & Child Health, Red Cross Children's Hospital and SA-MRC unit of Child & Adolescent Health, University of Cape Town, Cape Town, South Africa., Zambon M; Reference Microbiology, Public Health England, Faculty of Medicine, Imperial College, London, UK., Bont L; Department of Paediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, Netherlands; ReSViNET Foundation, Julius Clinical, Zeist, Netherlands. Electronic address: l.bont@umcutrecht.nl.

Publikováno v: The Lancet. Infectious diseases [Lancet Infect Dis] 2023 Jan; Vol. 23 (1), pp. e2-e21. Date of Electronic Publication: 2022 Aug 08.

Use of compressed sensing to expedite high-throughput diagnostic testing for COVID-19 and beyond.

Autor: Waldstein KA; Interdisciplinary Graduate Program in Immunology, University of Iowa, Iowa City, Iowa, United States of America., Yi J; Department of Electrical and Computer Engineering, University of Iowa, Iowa City, Iowa, United States of America., Cho M; Department of Electrical and Computer Engineering, Penn State Behrend, Erie, Pennsylvania, United States of America., Mudumbai R; Department of Electrical and Computer Engineering, University of Iowa, Iowa City, Iowa, United States of America., Wu X; Department of Electrical and Computer Engineering, University of Iowa, Iowa City, Iowa, United States of America., Varga SM; Interdisciplinary Graduate Program in Immunology, University of Iowa, Iowa City, Iowa, United States of America.; Department of Microbiology and Immunology, University of Iowa, Iowa City, Iowa, United States of America.; Department of Pathology, University of Iowa, Iowa City, Iowa, United States of America., Xu W; Department of Electrical and Computer Engineering, University of Iowa, Iowa City, Iowa, United States of America.

Publikováno v: PLoS computational biology [PLoS Comput Biol] 2022 Oct 24; Vol. 18 (10), pp. e1010629. Date of Electronic Publication: 2022 Oct 24 (Print Publication: 2022).

Prefusion F-Based Polyanhydride Nanovaccine Induces Both Humoral and Cell-Mediated Immunity Resulting in Long-Lasting Protection against Respiratory Syncytial Virus.

Autor: Stephens LM; Interdisciplinary Graduate Program in Immunology, University of Iowa, Iowa City, IA., Ross KA; Department of Chemical and Biological Engineering, Iowa State University, Ames, IA.; Nanovaccine Institute, Ames, IA., Waldstein KA; Interdisciplinary Graduate Program in Immunology, University of Iowa, Iowa City, IA., Legge KL; Interdisciplinary Graduate Program in Immunology, University of Iowa, Iowa City, IA.; Nanovaccine Institute, Ames, IA.; Department of Microbiology and Immunology, University of Iowa, Iowa City, IA.; Department of Pathology, University of Iowa, Iowa City, IA; and., McLellan JS; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX., Narasimhan B; Department of Chemical and Biological Engineering, Iowa State University, Ames, IA.; Nanovaccine Institute, Ames, IA., Varga SM; Interdisciplinary Graduate Program in Immunology, University of Iowa, Iowa City, IA; varga@uiowa.edu.; Nanovaccine Institute, Ames, IA.; Department of Microbiology and Immunology, University of Iowa, Iowa City, IA.; Department of Pathology, University of Iowa, Iowa City, IA; and.

Publikováno v: Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2021 May 01; Vol. 206 (9), pp. 2122-2134. Date of Electronic Publication: 2021 Apr 07.